TY - JOUR
T1 - New Model for Predicting Malignancy in Patients With Intraductal Papillary Mucinous Neoplasm
AU - Shimizu, Yasuhiro
AU - Hijioka, Susumu
AU - Hirono, Seiko
AU - Kin, Toshifumi
AU - Ohtsuka, Takao
AU - Kanno, Atsushi
AU - Koshita, Shinsuke
AU - Hanada, Keiji
AU - Kitano, Masayuki
AU - Inoue, Hiroyuki
AU - Itoi, Takao
AU - Ueki, Toshiharu
AU - Matsuo, Keitaro
AU - Yanagisawa, Akio
AU - Yamaue, Hiroki
AU - Sugiyama, Masanori
AU - Okazaki, Kazuichi
PY - 2020/7/1
Y1 - 2020/7/1
N2 - OBJECTIVE: To create a simple, objective model to predict the presence of malignancy in patients with intraductal papillary mucinous neoplasm (IPMN), which can be easily applied in daily practice and, importantly, adopted for any lesion types. BACKGROUND: No predictive model for malignant IPMN has been widely applied in clinical practice. METHODS: The clinical details of 466 patients with IPMN who underwent pancreatic resection at 3 hospitals were retrospectively analyzed for model development. Then, the model was validated in 664 surgically resected patients at 8 hospitals in Japan.In the preoperative examination, endoscopic ultrasonography (EUS) was considered to be essential to observe mural nodules in both the model development and external validation sets. Malignant IPMNs were defined as those with high-grade dysplasia and associated invasive carcinoma. RESULTS: Of the 466 patients, 258 (55%) had malignant IPMNs (158 high-grade dysplasia, 100 invasive carcinoma), and 208 (45%) had benign IPMNs. Logistic regression analysis resulted in 3 variables (mural nodule size, main pancreatic duct diameter, and cyst size) being selected to construct the model. The area under the receiver operating characteristic curve (AUC) for the model was 0.763. In external validation sets, the pathological diagnosis was malignant and benign IPMN in 351 (53%) and 313 (47%) cases, respectively. For the external validation, the malignancy prediction ability of the model corresponded to an AUC of 0.725. CONCLUSION: This predictive model provides important information for physicians and patients in assessing an individual's risk for malignancy and may help to identify patients who need surgery.
AB - OBJECTIVE: To create a simple, objective model to predict the presence of malignancy in patients with intraductal papillary mucinous neoplasm (IPMN), which can be easily applied in daily practice and, importantly, adopted for any lesion types. BACKGROUND: No predictive model for malignant IPMN has been widely applied in clinical practice. METHODS: The clinical details of 466 patients with IPMN who underwent pancreatic resection at 3 hospitals were retrospectively analyzed for model development. Then, the model was validated in 664 surgically resected patients at 8 hospitals in Japan.In the preoperative examination, endoscopic ultrasonography (EUS) was considered to be essential to observe mural nodules in both the model development and external validation sets. Malignant IPMNs were defined as those with high-grade dysplasia and associated invasive carcinoma. RESULTS: Of the 466 patients, 258 (55%) had malignant IPMNs (158 high-grade dysplasia, 100 invasive carcinoma), and 208 (45%) had benign IPMNs. Logistic regression analysis resulted in 3 variables (mural nodule size, main pancreatic duct diameter, and cyst size) being selected to construct the model. The area under the receiver operating characteristic curve (AUC) for the model was 0.763. In external validation sets, the pathological diagnosis was malignant and benign IPMN in 351 (53%) and 313 (47%) cases, respectively. For the external validation, the malignancy prediction ability of the model corresponded to an AUC of 0.725. CONCLUSION: This predictive model provides important information for physicians and patients in assessing an individual's risk for malignancy and may help to identify patients who need surgery.
UR - http://www.scopus.com/inward/record.url?scp=85089708443&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089708443&partnerID=8YFLogxK
U2 - 10.1097/SLA.0000000000003108
DO - 10.1097/SLA.0000000000003108
M3 - Article
C2 - 30499803
AN - SCOPUS:85089708443
VL - 272
SP - 155
EP - 162
JO - Annals of Surgery
JF - Annals of Surgery
SN - 0003-4932
IS - 1
ER -